Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK7-IN-6 is a highly effective and specific inhibitor (IC50 ≤100 nM) of cyclin-dependent kinase 7 (CDK7). It showcases remarkable selectivity, with more than a 200-fold preference for CDK7 over CDK1, CDK2, and CDK5. This compound holds significant potential for cancer research purposes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | CDK7-IN-6 is a highly effective and specific inhibitor (IC50 ≤100 nM) of cyclin-dependent kinase 7 (CDK7). It showcases remarkable selectivity, with more than a 200-fold preference for CDK7 over CDK1, CDK2, and CDK5. This compound holds significant potential for cancer research purposes. |
Targets&IC50 | CDK7:≤100 nM (IC50) |
In vitro | CDK7-IN-6 effectively suppresses cell viability in various cancer cell lines, including HCT116, H460, MV4-11, A2780, and OVCAR cells, demonstrating potent inhibition (IC50 ≤1 μM)[1]. |
Alias | CDK7-IN-6 |
Molecular Weight | 524.07 |
Formula | C26H34ClN9O |
Cas No. | 2378710-04-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.